AI Market Mood: Stock Dashboard
BLCO
Fundamental
Company: Bausch + Lomb Corp
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: Canada
Exchange: NYSE
Index: -
P/E: -
EPS (ttm): -0.77
Insider Own: 89.69%
Shs Outstand: 353.80M
Perf Week: -0.92%
Market Cap: 5.12B
Forward P/E: 18.27
EPS next Y: 0.79
Insider Trans: 0.01%
Shs Float: 36.47M
Perf Month: 0.24%
Enterprise Value: 9.88B
PEG: -
EPS next Q: 0.16
Inst Own: 10.14%
Short Float: 11.13%
Perf Quarter: 22.67%
Income: -273.00M
P/S: 1.05
EPS this Y: -18.49%
Inst Trans: 3.07%
Short Ratio: 5.15
Perf Half Y: -9.36%
Sales: 4.89B
P/B: 0.80
EPS next Y Percentage: 54.27%
ROA: -2.02%
Short Interest: 4.06M
Perf YTD: -19.85%
Book/sh: 18.20
P/C: 18.83
EPS next 5Y: 17.05%
ROE: -4.22%
52W High: 21.69 -33.26%
Perf Year: -9.47%
Cash/sh: 0.77
P/FCF: -
EPS past 3/5Y: - -
ROIC: -2.40%
52W Low: 10.45 38.52%
Perf 3Y: -6.61%
Dividend Est.: -
EV/EBITDA: 17.76
Sales past 3/5Y: 8.36% 4.87%
Gross Margin: 54.08%
Volatility W: 2.74%
Volatility M: 3.71%
Perf 5Y: -
Dividend TTM: -
EV/Sales: 2.02
EPS Y/Y TTM: 40.43%
Oper. Margin: 2.60%
ATR (14): 0.46
Perf 10Y: -
Dividend Ex-Date: -
Quick Ratio: 0.98
Sales Y/Y TTM: 8.81%
Profit Margin: -5.58%
RSI (14): 55.65
Recom: 2.44
Dividend Gr. 3/5Y: - -
Current Ratio: 1.55
EPS Q/Q: 59.16%
SMA20: 2.37%
Beta: 0.62
Target Price: 14.96
Payout: -
Debt/Eq: 0.77
Sales Q/Q: 5.10%
SMA50: 5.83%
Rel Volume: 0.36
Prev Close: 14.53
Employees: 13500
LT Debt/Eq: 0.77
Earnings: Jul 30 BMO
SMA200: -4.31%
Avg Volume: 788.65K
Price: 14.48
IPO: May 06, 2022
Option/Short: Yes / Yes
EPS/Sales Surpr.: 12.36% 1.46%
Trades:
Volume: 277,045
Change: -0.38%
Technical:
Latest News:
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Bausch + Lomb ... very bullish
AMGN BLCO
Summary: Analysts have expressed bullish sentiments on Amgen (AMGN) and Bausch + Lomb Corporation (BLCO) in the Healthcare sector. Wells Fargo analyst maintained a Buy rating on both companies, setting price targets of $320.00 for Amgen and $23.00 for BLCO. The consensus ratings for these stocks suggest potential upsides of 14.1% and 31.5% respectively.
Full article2024-04-24T20:31:52Z